A Potent 5-HT2A Receptor Agonist TCB-2 Exerts Rapid Antidepressant-Like and Anxiolytic-Like Effects in Mice

被引:0
作者
Koike, Hiroyuki [1 ]
Horinokita, Ichiro [1 ]
Suzuki, Mikio [1 ]
Futamura, Takashi [1 ]
机构
[1] Otsuka Pharmaceut Co Ltd, Tokushima 77101, Japan
关键词
Serotonin 5-HT2A Receptor; TCB-2; Psychedelics; Animal Models;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
P360
引用
收藏
页码:270 / 271
页数:2
相关论文
共 43 条
  • [21] Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: involvement of dopaminergic system
    Cavalcante Melo, Francisca Helvira
    Moura, Brinell Arcanjo
    de Sousa, Damiao Pergentino
    Mendes de Vasconcelos, Silvania Maria
    Macedo, Danielle Silveira
    de Franca Fonteles, Marta Maria
    de Barros Viana, Glauce Socorro
    Florenco de Sousa, Francisca Clea
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (03) : 362 - 367
  • [22] Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats
    Wesolowska, Anna
    Rychtyk, Joanna
    Gdula-Argasinska, Joanna
    Gorecka, Katarzyna
    Wilczynska-Zawal, Natalia
    Jastrzebska-Wiesek, Magdalena
    Partyka, Anna
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2105 - 2127
  • [23] Xiaoyaosan exerts anxiolytic-like effects by down-regulating the TNF-α/JAK2-STAT3 pathway in the rat hippocampus
    Li, Xiao-Juan
    Ma, Qing-Yu
    Jiang, You-Ming
    Bai, Xiao-Hui
    Yan, Zhi-Yi
    Liu, Qun
    Pan, Qiu-Xia
    Liu, Yue-Yun
    Chen, Jia-Xu
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression
    Gupta, Deepali
    Radhakrishnan, Mahesh
    Kurhe, Yeshwant
    Thangaraj, Devadoss
    Prabhakar, Visakh
    Kanade, Prateek
    ACTA PHARMACOLOGICA SINICA, 2014, 35 (12) : 1493 - 1503
  • [25] Protective effects of 5-HT1A receptor antagonist and 5-HT2A receptor agonist on the biochemical and histological features in a rat model of Alzheimer's disease
    Afshar, Simin
    Shahidi, Siamak
    Rohani, Ali Haeri
    Asl, Sara Soleimani
    Komaki, Alireza
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 96 : 140 - 147
  • [26] Serotonin 5-HT1B receptors mediate the antidepressant-and anxiolytic-like effects of ventromedial prefrontal cortex deep brain stimulation in a mouse model of social defeat
    Silk, Esther
    Diwan, Mustansir
    Rabelo, Thallita
    Katzman, Hailey
    Campos, Ana Carolina P.
    Gouveia, Flavia Venetucci
    Giacobbe, Peter
    Lipsman, Nir
    Hamani, Clement
    PSYCHOPHARMACOLOGY, 2022, 239 (12) : 3875 - 3892
  • [27] Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models
    Louis, Caroline
    Stemmelin, Jeanne
    Boulay, Denis
    Bergis, Olivier
    Cohen, Caroline
    Griebel, Guy
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2008, 89 (01) : 36 - 45
  • [28] Partial mGlu5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice
    Palucha-Poniewiera, Agnieszka
    Rafalo-Ulinska, Anna
    Santocki, Michal
    Babii, Yana
    Kaczorowska, Katarzyna
    PHARMACOLOGICAL REPORTS, 2024, 76 (03) : 504 - 518
  • [29] Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: Evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test
    Barbalho, Cilene Aparecida
    Nunes-de-Souza, Ricardo L.
    Canto-de-Souza, Azair
    BRAIN RESEARCH, 2009, 1267 : 65 - 76
  • [30] Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response
    Erkizia-Santamaria, I
    Alles-Pascual, R.
    Horrillo, I
    Meana, J. J.
    Ortega, J. E.
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 154